Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.

ABSTRACT:

SUBMITTER: Schiff AE 

PROVIDER: S-EPMC11009046 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature